Association between the BRCA2 rs144848 polymorphism and cancer susceptibility: a meta-analysis
- PMID: 28418854
- PMCID: PMC5503656
- DOI: 10.18632/oncotarget.16242
Association between the BRCA2 rs144848 polymorphism and cancer susceptibility: a meta-analysis
Abstract
The BRCA2 gene plays an important role in cancer carcinogenesis, and polymorphisms in this gene have been associated with cancer risk. The BRCA2 rs144848 polymorphism has been associated with several cancers, but results have been inconsistent. In the present study, a meta-analysis was performed to assess the association between the rs144848 polymorphism and cancer risk. Literature was searched from the databases of PubMed, Embase and Google Scholar before April 2016. The fixed or random effects model was used to calculate pooled odd ratios on the basis of heterogeneity. Meta-regression, sensitivity analysis, subgroup analysis and publication bias assessment were also performed using STATA 11.0 software according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2009. A total of 40 relevant studies from 30 publications including 34,911 cases and 48,329 controls were included in the final meta-analysis. Among them, 22 studies focused on breast cancer, seven on ovarian cancer, five on non-Hodgkin lymphoma, and the remaining six studies examined various other cancers. The meta-analysis results showed that there were significant associations between the rs144848 polymorphism and cancer risk in all genetic models. Stratified by cancer type, the rs144848 polymorphism was associated with non-Hodgkin lymphoma. Stratified by study design, the allele model was associated with breast cancer risk in population-based studies. The meta-analysis suggests that the BRCA2 rs144848 polymorphism may play a role in cancer risk. Further well-designed studies are warranted to confirm these results.
Keywords: BRCA2; cancer; meta-analysis; polymorphism; susceptibility.
Conflict of interest statement
We declared that there is no duality of interest associated with this manuscript.
Figures






Similar articles
-
BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.Breast Cancer Res Treat. 2010 Sep;123(2):487-90. doi: 10.1007/s10549-010-0767-5. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135345
-
Association of BRCA2 N372H polymorphism with cancer susceptibility: a comprehensive review and meta-analysis.Sci Rep. 2014 Oct 28;4:6791. doi: 10.1038/srep06791. Sci Rep. 2014. PMID: 25348552 Free PMC article.
-
Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.Mol Genet Genomics. 2015 Aug;290(4):1235-45. doi: 10.1007/s00438-014-0985-3. Epub 2015 Jan 9. Mol Genet Genomics. 2015. PMID: 25573780
-
Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.World J Gastroenterol. 2014 Nov 28;20(44):16765-73. doi: 10.3748/wjg.v20.i44.16765. World J Gastroenterol. 2014. PMID: 25469049 Free PMC article. Review.
-
Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.J BUON. 2015 May-Jun;20(3):902-17. J BUON. 2015. PMID: 26214646 Review.
Cited by
-
The association between XRCC3 rs1799794 polymorphism and cancer risk: a meta-analysis of 34 case-control studies.BMC Med Genomics. 2021 Apr 30;14(1):117. doi: 10.1186/s12920-021-00965-4. BMC Med Genomics. 2021. PMID: 33931047 Free PMC article.
-
Identification of Variants (rs11571707, rs144848, and rs11571769) in the BRCA2 Gene Associated with Hereditary Breast Cancer in Indigenous Populations of the Brazilian Amazon.Genes (Basel). 2021 Jan 22;12(2):142. doi: 10.3390/genes12020142. Genes (Basel). 2021. PMID: 33499154 Free PMC article.
-
Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk.Biosci Rep. 2020 Jul 31;40(7):BSR20191825. doi: 10.1042/BSR20191825. Biosci Rep. 2020. PMID: 32597485 Free PMC article.
-
The Genomic Landscape of Colorectal Cancer in the Saudi Arabian Population Using a Comprehensive Genomic Panel.Diagnostics (Basel). 2023 Sep 19;13(18):2993. doi: 10.3390/diagnostics13182993. Diagnostics (Basel). 2023. PMID: 37761360 Free PMC article.
-
CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.Stem Cell Reports. 2018 Apr 10;10(4):1412-1425. doi: 10.1016/j.stemcr.2018.02.009. Epub 2018 Mar 15. Stem Cell Reports. 2018. PMID: 29551673 Free PMC article.
References
-
- Easton D. New insights into genetic susceptibility to breast cancer. Cancer Prevention Research. 2010:3.
-
- Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, et al. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Breast Cancer Research. 2011:13. - PMC - PubMed
-
- Narod SA. Genes, the environment, and breast cancer. The Lancet. 2010;375:2123–2124. - PubMed
-
- Vici P, Di Benedetto A, Ercolani C, Pizzuti L, Di Lauro L, Sergi D, Sperati F, Terrenato I, Dattilo R, Botti C, Fabi A, Ramieri MT, Mentuccia L, et al. Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis. Oncotarget. 2015;6:42773–42780. doi: 10.18632/oncotarget.6001. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous